Biotech

All Articles

Vaxcyte rises on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what analysts called "remarkable" period 1/2 information for its own 31-valent p...

Recursion's human brain health condition trial reveals scant documentation of efficiency

.Recursion has actually discovered through a very early exam of its tech-enabled strategy to medicin...

Acepodia, Pfizer click on with each other for chemistry-based cell therapy

.Contact it a situation of great chemistry: Acepodia, a biotech based on Nobel Prize-winning science...

Praxis epilepsy medicine lowers confiscations in period 2 hearing

.Praxis Accuracy Medicines has racked up another midphase win in epilepsy this year, with its own sa...

Three officers resign as Dyne posts combined data for DMD candidate

.After getting away from a professional hold numerous years back, Dyne Therapeutics has exposed new ...

Arrowhead fires off phase 3 records in uncommon metabolic condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own give before a prospective showdown with Ionis, posting ...

Pfizer, Valneva reveal lyme condition shot efficient for 2nd booster

.Pfizer and Valneva might possess concerning pair of more years to hang around before they create th...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a conversation with Ayla Ellison, Strong Biotech Managing Editor as well as Mich...

New records demonstrate how Bayer's asundexian failed to prevent strokes

.Bayer suspended the stage 3 test for its element XIa inhibitor asundexian late in 2013 after the me...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own a number of sclerosis (MS) med tolebrutinib to the F...